BeOne Medicines Ltd. American Depositary Shares
ONC · Nasdaq
Analyst Consensus
Buy
Analyst Ratings Synthesis
The displayed consensus is Buy, but it is supported by zero analysts, making the rating count unusable as evidence of broad coverage. The only stated target is a mean of $412; low and high targets are unavailable, so target clustering and the width of the range cannot be assessed. No named analyst or firm is identified as most or least bullish. The supplied material also reports no target or rating revisions during the week. The substantive disagreement behind the displayed target is therefore unavailable. The sole research item is a Zacks preview focused on second-quarter estimates beyond revenue and EPS, not a documented rating action or target rationale.
Rating Actions
No individual rating actions have been captured for ONCyet. Consensus figures above come from Nasdaq's aggregate feed.
